SCHEMBL7815084

SCHEMBL7815084

CCOc1cc2c(cc1F)n[c]n2C

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 1/20 0.35
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
L3MBTL1 Q9Y468 3/20 0.33
LMNA P02545 2/20 0.33
TUBB1 Q9H4B7 1/20 0.33
KDM1A O60341 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 2/20 0.32
P2RX7 Q99572 2/20 0.32
EGFR P00533 2/20 0.32
FBP1 P09467 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
MAPT P10636 1/20 0.31
NR3C1 P04150 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7818577 0.94 EGLN1 (0.37) EGLN1GAATSHRL3MBTL1LMNA
SCHEMBL7814921 0.74 CYP11B1 (0.36) HTTMAPT
SCHEMBL7812496 0.72 MAPT (0.55) TSHRLMNAALDH1A1HTTMEN1
SCHEMBL7814303 0.72 MAPT (0.48) TSHRLMNAALDH1A1HTTMEN1
SCHEMBL5982809 0.72 FGFR1 (0.39) GAATSHRL3MBTL1LMNAALDH1A1
SCHEMBL1831006 0.68 KMT2A (0.38) L3MBTL1ALDH1A1MEN1KMT2AMAPT
SCHEMBL7812397 0.68 NQO2 (0.36) TSHRL3MBTL1LMNAHTTMEN1
SCHEMBL2157981 0.66 CYP11B1 (0.39) ALDH1A1MEN1KMT2A
SCHEMBL5982758 0.65 PTPN1 (0.40) GAALMNAALDH1A1HTTMEN1
SCHEMBL7814717 0.65 LMNA (0.33) TSHRL3MBTL1LMNAHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0745600-B1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-10-24 EP disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 EP disclosed